Location · Brooksville, FL
Clinical trials in Brooksville, FL
7 recruiting studies have a site in Brooksville, and 0 of them accept healthy volunteers.
7 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
Generate Biomedicines
- Location
- Brooksville, FL + 35 other US sites
- Eligibility basics
- Ages 12–80
- RecruitingPhase 4
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Takeda
- Location
- Brooksville, FL + 77 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Hoffmann-La Roche
- Location
- Brooksville, FL + 91 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 3
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Boehringer Ingelheim
- Location
- Brooksville, FL + 154 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Boehringer Ingelheim
- Location
- Brooksville, FL + 123 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
GlaxoSmithKline
- Location
- Brooksville, FL + 50 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
GlaxoSmithKline
- Location
- Brooksville, FL + 7 other US sites
- Eligibility basics
- Ages 18+